17.04.2024 • News

Vantage Expands Taurate Manufacturing Capacity in Germany

US-based Vantage Specialty Chemicals is to expand taurate capacity at its major manufacturing site in Leuna, Germany, in particular for the production of N-methyltaurine.

The multi-million-dollar investment, Vantage said, is a two-phase expansion that will almost triple the site’s capacity for N-methyltaurine, a strategic building block. The initial phase was completed in September 2022 with the second phase expected to come online in early 2025.

Steve Doktycz, CEO of Vantage Specialty Chemicals, said: “As a longstanding leader in natural product derivatives, the expansion in Leuna reinforces our leadership in the taurates value chain. The additional capacity will allow us to meet global demand for mild surfactants, particularly in personal care where formulators favor our effective, sulfate-free surfactant portfolio for applications targeting sensitive skin and scalp irritation."

In addition to adding significant product capacity, the investment will further strengthen energy efficiency at the site, reducing steam consumption by approximately 40% annually which relates to approximately 1,000 t/y of CO2 emissions, the company stated.

The Leuna site became part of Vantage in 2019 and claims to be one of the world’s leading producers of taurates and their building blocks. The site also manufactures specialty surfactants and intermediates that support Vantage’s consumer and industrial business divisions.

© motortion - stock.adobe.com
© motortion - stock.adobe.com

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.